3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 0 0 0 0 0 0999 V2000
3.1039 0.5623 0.1076 S 0 0 0 0 0 0 0 0 0 0 0 0
2.1940 -2.2903 -0.0362 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.8454 -1.9079 -0.0551 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5598 -0.0316 0.0501 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9072 0.2076 -0.0059 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6891 -0.6868 0.0061 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6592 1.4174 0.2456 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8217 1.0954 -1.2468 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9030 1.0577 1.2645 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1582 -0.6692 -0.0574 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9802 1.9057 -0.3039 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8274 -0.6603 0.0314 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6505 1.5943 1.3297 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.0922 2.0488 -0.2030 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.6076 0.8119 -1.9610 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.0203 2.1531 -1.0385 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9001 1.0026 -1.8319 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.6063 2.1022 1.1381 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3116 0.6114 2.0728 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9242 1.1321 1.6633 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.2333 -1.3160 0.8250 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.1681 -1.3169 -0.9424 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.0665 -0.0562 -0.0930 H 0 0 0 0 0 0 0 0 0 0 0 0
1.9393 2.0112 -1.3927 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2946 2.8544 0.1387 H 0 0 0 0 0 0 0 0 0 0 0 0
1 11 1 0 0 0 0
1 12 1 0 0 0 0
2 12 2 0 0 0 0
3 6 2 0 0 0 0
4 6 1 0 0 0 0
4 7 1 0 0 0 0
4 12 1 0 0 0 0
5 6 1 0 0 0 0
5 8 1 0 0 0 0
5 9 1 0 0 0 0
5 10 1 0 0 0 0
7 11 1 0 0 0 0
7 13 1 0 0 0 0
7 14 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
8 17 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
9 20 1 0 0 0 0
10 21 1 0 0 0 0
10 22 1 0 0 0 0
10 23 1 0 0 0 0
11 24 1 0 0 0 0
11 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2,2-dimethyl-1-(2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one
4.2 InChl
InChI=1S/C8H13NOS2/c1-8(2,3)6(10)9-4-5-12-7(9)11/h4-5H2,1-3H3
4.3 InChlKey
QPFBZLPXTOTDIF-UHFFFAOYSA-N
4.4 Canonical SMILES
CC(C)(C)C(=O)N1CCSC1=S
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病